Year |
Citation |
Score |
2016 |
Daenzer JM, Jumbo-Lucioni PP, Hopson ML, Garza KR, Ryan EL, Fridovich-Keil JL. Acute and long-term outcomes in a Drosophila melanogaster model of classic galactosemia occur independently of galactose-1-phosphate accumulation. Disease Models & Mechanisms. PMID 27562100 DOI: 10.1242/Dmm.022988 |
0.435 |
|
2014 |
Jumbo-Lucioni PP, Ryan EL, Hopson ML, Bishop HM, Weitner T, Tovmasyan A, Spasojevic I, Batinic-Haberle I, Liang Y, Jones DP, Fridovich-Keil JL. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia. Antioxidants & Redox Signaling. 20: 2361-71. PMID 23758052 DOI: 10.1089/Ars.2012.5122 |
0.72 |
|
2013 |
Spencer JB, Badik JR, Ryan EL, Gleason TJ, Broadaway KA, Epstein MP, Fridovich-Keil JL. Modifiers of ovarian function in girls and women with classic galactosemia. The Journal of Clinical Endocrinology and Metabolism. 98: E1257-65. PMID 23690308 DOI: 10.1210/Jc.2013-1374 |
0.558 |
|
2013 |
Ryan EL, Lynch ME, Taddeo E, Gleason TJ, Epstein MP, Fridovich-Keil JL. Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia. Journal of Inherited Metabolic Disease. 36: 1049-61. PMID 23319291 DOI: 10.1007/S10545-012-9575-X |
0.667 |
|
2012 |
Ryan EL, DuBoff B, Feany MB, Fridovich-Keil JL. Mediators of a long-term movement abnormality in a Drosophila melanogaster model of classic galactosemia. Disease Models & Mechanisms. 5: 796-803. PMID 22736462 DOI: 10.1242/Dmm.009050 |
0.729 |
|
2010 |
Kushner RF, Ryan EL, Sefton JM, Sanders RD, Lucioni PJ, Moberg KH, Fridovich-Keil JL. A Drosophila melanogaster model of classic galactosemia. Disease Models & Mechanisms. 3: 618-27. PMID 20519569 DOI: 10.1242/Dmm.005041 |
0.662 |
|
Show low-probability matches. |